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Abstract
Hepatitis C virus (HCV) Core protein is implicated in viral pathogenesis by the modulation of hepatocyte gene expression and function.
To determine the effect of Core protein on the cell-cycle control of hepatocytes, a HepG2 cell line containing a Flag-tagged Core under the
control of an inducible promoter was generated. Initial Core protein expression included the presence of unprocessed (191 aa) and processed
(173 aa) forms of the Core proteins with the processed form becoming dominant later. Expression of the 191 aa form of Core protein
corresponded to an increase in the expression of the p21, a decrease in cdk2-dependent kinase activity, and a decrease in the percentage of
cells in S-phase along with an accumulation of cells in the G0/G1 phase of the cell cycle. As the processed form accumulated, the p21 levels
started to decline, suggesting that Core protein regulates p21 expression in a biphasic manner. These findings implicate Core protein in
potentially modulating hepatocyte cell cycle differentially in the early stages of infection through biphasic regulation of p21 cdk kinase
inhibitor.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
The hepatitis C virus (HCV) is the etiologic agent of
acute and chronic hepatitis affecting more than 100 million
people worldwide (Uchida, 1994). Chronic hepatitis is one
of the leading causes of liver cirrhosis and hepatocellular
carcinoma (Saito et al., 1990), but the precise role of HCV
in the development of this cancer has not been elucidated.
HCV, a member of the flavivirus family, has a 9.5-kb
positive single-stranded RNA genome, which encodes a
polyprotein that is processed into at least 10 different struc-
tural and nonstructural proteins (Choo et al., 1989; Ray and
Ray, 2001). The HCV core protein is derived from the
N-terminus of the polypeptide and has a highly basic N-
terminal region and a highly hydrophobic C-terminus
(Kunkel and Watowich, 2002). In addition to being the
major component of the viral nucleocapsid, this multifunc-
tional protein has also been implicated in hepatocyte pro-
liferation and transformation. However, its role in hepato-
cyte proliferation and tumorogenesis has not been well
elucidated.
HCV Core protein is proteolytically processed and sev-
eral molecular weight variants of Core protein have been
identified. The 191 amino acid (aa) form encodes a 21-kDa
protein. This 21-kDa form can be further proteolytically
processed to a p19-kDa form that consists of 173 aa or to a
minor 16-kDa form (Lo et al., 1995). Lo et al. (1995)
reported that the p21 and p19 forms localized to the cyto-
plasm. Furthermore, Yamanaka et al. (2002) reported that
191 aa form of Core localized to the cytoplasm, while the
173 aa form could localize to the nucleus. Yasui et al.
(1998) report that the processed form of Core protein re-
sides in both the cytoplasm and the nucleus, but that the
nuclear form has higher order structure that differs from the
structure of the cytoplasmic form. In addition, Core protein
can be degraded by ubiquitin-mediated proteolysis and that
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processing of the C-terminal domain may affect the ubiq-
uitination process (Suzuki et al., 2001). The distinct subcel-
lular localization and differing stability of the various forms
of Core protein raises the possibility that they may have
distinct biological functions and may impact viral pathogen-
esis. However, our knowledge of the functions of these
different core proteins remains limited. It is also not known
how the combination of both immature and mature forms of
Core protein will impact hepatocyte proliferation and func-
tion.
Effects of the Core protein on various cellular processes
have been studied in human and nonhuman cells. Expres-
sion of the Core protein in the liver of transgenic mice
induces hepatic steatosis (Moriya et al., 1997) and promotes
the development of hepatocellular carcinomas (Moriya et
al., 1998). The ability of Core protein to mimic the HCV
disease process argues that the expression of this protein is
integral to HCV pathogenesis. Cells that stably express Core
protein exhibit an accumulation of lipid droplets and the
Core protein colocalizes with apolipoprotein AII (Barba et
al., 1997; Sabile et al., 1999). Some studies indicate that
HCV Core protein cooperates with the ras oncogene to
transform primary rat embryo fibroblasts (REF) (Ray et al.,
1996), while others argue that while Core has oncogenic
potential, it is not sufficient to cooperate, with ras to trans-
form primary REF (Chang et al., 1998). In addition, Core
protein can activate the c-myc promoter but suppresses the
fos promoter (Ray et al., 1995). Some studies have reported
that cyclin E, a protein instrumental in the transversal of the
G1/S checkpoint, is elevated in cells expressing Core protein
(Cho et al., 2001a). Lu et al. (1999) reported that the p53
tumor suppressor is activated by expression of Core protein.
A number of studies found that Core protein modulates the
expression of the p21 cell-cycle-dependent kinase (cdk)
inhibitor, a target of the p53 tumor suppressor. However, the
results of these studies are conflicting. While some studies
indicate that Core protein represses expression of the p21
promoter (Ray et al., 1998; Jung et al., 2001; Yoshida et al.,
2001), others report that Core protein enhances p21 expres-
sion (Lu et al., 1999; Otsuka et al., 2000). A recent study
indicated that the 191 aa form of Core localizes to the
cytoplasm and enhances the expression of the p21 (cdk
kinase inhibitor), while the processed 173 form represses
p21 expression (Yamanaka et al., 2002). These studies sug-
gest that Core protein plays a pivotal role in HCV patho-
genesis and modulation of distinct cell-cycle regulatory
molecules is a component of this process. However, the
kinetics of the expression of Core protein forms in context
of hepatocyte cell-cycle modulation are not known.
The p21 protein belongs to a family of cdk inhibitors and
modulates various biological processes such as cell growth,
differentiation, and apoptosis (Dotto, 2000; Harper and
Elledge, 1996). In mammalian cells, p21 is found in com-
plexes that consist of cyclins (D and E), cdks, and prolif-
erating cell nuclear antigen (PCNA), a subunit of DNA
polymerase (Zhang et al., 1993; Chuang et al., 1997). By
interacting directly with PCNA, p21 prevents DNA synthe-
sis and regulates DNA methylation (Li et al., 1994). It is
thus possible that Core protein-dependent modulation of
p21 may modify multiple cellular processes and affect cell
transformation. However, the effect of immature and mature
forms of Core protein on hepatocyte cell-cycle progression
has not been fully examined.
To determine the role of Core protein in p21 regulation
and hepatocyte cell-cycle modulation, we generated a
HepG2-derived cell line in which the expression of core
protein is under the control of an inducible promoter. We
enhanced the detection of Core protein by tagging the
amino-terminus of the protein with the Flag epitope. Two
isoforms of Core protein were present at early time points
following the induction, which corresponded to the imma-
ture 191 aa form and the mature 173 aa form that have been
previously reported (Yamanaka et al., 2002). At early time
points postinduction (4 and 8 h), we observed that the two
molecular weight forms were equally abundant in core-
expressing cells, while at later times (16–48 h), the mature
form accumulated to become the dominant species. Western
blot analysis revealed elevation of the p21 inhibitor expres-
sion early following induction and was coincident with the
appearance of the immature form of Core protein. As the
mature form of Core protein accumulated at 16 h, the level
of p21 started to decline. The elevation of p21 corresponded
with a decrease in cdk2-dependent kinase activity and was
accompanied by a decrease in the percentage of cells in
S-phase along with an accumulation of cells in the G0/G1
phase of the cell cycle. This study suggests that the imma-
ture form of Core protein enhances the expression of the
p21 cdk inhibitor, which in turn represses cellular prolifer-
ation.
Results
Construction of an inducible system for the expression of
HCV Core protein in HepG2 cells
To study the effect of HCV Core on hepatocytes in a
consistent manner, we generated a HepG2 cell line that can
be conditionally induced to express Core protein(s). An
inducible system reduces variables associated with transient
transfection systems and also minimizes the permanent and
or injurious effects of constitutive and viral transduction
systems. Due to the lack of availability of a sensitive Core
protein antibody, we subcloned the full-length coding se-
quence of HCV-1b Core protein (191 aa) to include a
3XFLAG epitope (Sigma-Aldrich) upstream of the Core
start codon. The amino-terminally FLAG-tagged Core se-
quence was further subcloned into the ecdysone-inducible
pIND vector (Invitrogen, Carlsbad, CA) to make pIND-3X-
Core plasmid (Fig. 1A). The predicted size of the full-length
FLAG-tagged Core protein is approximately 27 kDa. Ad-
dition of Ponasterone-A resulted in the induction of receptor
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dimerization, which in turn stimulated the expression of the
FLAG-tagged Core protein. The immediate expression of a
viral protein of interest upon induction by this system had
been previously demonstrated in our laboratory (Ndolo et
al., 2002). Using this inducible system, we generated a tool
to monitor the early effects of HCV Core expression on
hepatocytes and cell-cycle-related changes.
To study the effect of Core expression on hepatocytes,
the pIND-Core and pVgRxR plasmids were introduced into
the HepG2 hepatocyte cell line. This cell line was chosen
because of its hepatic origin. More importantly, HepG2
cells express both p21 cdk kinase inhibitor and wild-type
p53. Individual clones were isolated and tested by Western
blot analysis for Core protein expression prior to and fol-
lowing the induction by treatment with Ponasterone-A.
Core protein was readily detectable in induced hepatocyte
cells using Flag antibodies as shown in Fig. 1B. A very
small amount of Core protein was detected in uninduced
cells, suggesting low basal levels of expression inherent in
this system. In contrast, commercially available antibodies
to Core could only detect the protein when it was highly
expressed (48 h postinduction).
Expression and processing kinetics of Core protein in
HepG2 cells
To optimize the expression of Core protein, cells were
induced with Ponasterone-A (10 M), harvested at 1, 2, 4,
8, 16, 24, and 48 h following induction, and subjected to
Western blot analysis using an anti-Flag antibody. Expres-
sion of Core protein was detected within 4 h of induction
and continued to increase for 48 h (Fig. 2). We did not
observed any obvious indications of apoptosis or cytopathic
effects in cells expressing Core protein. Two molecular
weight species of Core protein were detected 4 h after
induction, but at later time points (16 h) the smaller form
dominated. The larger species (27 kDa) corresponds to the
full-length native unprocessed FLAG-tagged 191 aa form.
The smaller species (approximately 25 kDa) corresponds to
the predicted size of a FLAG-tagged processed 173 aa form.
During the initial 8 h of induction, the ratios of unprocessed
(immature)-to-processed (mature) species of Core were
higher than at 16 h or later. The levels of the unprocessed
and processed forms were quantitated by densitometric
analysis. At 2, 4, and 8 h postinduction the ratio of unproc-
essed-to-processed forms of Core were 1:2, 1:3, and 1:10,
respectively. By 16 h the ratio of unprocessed-to-processed
Core was greater than 1:1000. By 48 h of induction the
mature form of the protein was so abundant that it obscured
detection of the immature form. The heightened sensitivity
of the Flag antibody enabled us to detect very early expres-
sion of the Core protein, identify two distinct molecular
weight species, and follow the kinetics of Core protein
processing. The accumulation of the mature form of Core
protein at later time points suggests that it may be the
dominant species present during the natural course of HCV
infection. Previous studies reported that the immature 191
aa form of Core protein localized to the cytoplasm, while
the mature, processed 173 aa form localized to the nucleus
Fig. 2. Kinetics of Core expression. Western blot analysis of cells induced
to express Core protein at 1, 2, 4, 8, 16, 24, and 48 h. At 4 h postinduction,
both forms of Core are abundant and with a ratio of immature to mature of
1:3. The mature form of Core protein is shown to be the predominant
species at 16 h postinduction (ratio of immature to mature of 1:1000) and
beyond. This panel demonstrates the detection of both the mature and the
immature forms of Core protein (marked with arrows). Western blots with
Anti-FLAG antibodies were used to detect Core. NT  nontransfected
cells, UI  uninduced cells.
Fig. 1. Inducible expression of Core protein in HepG2 hepatocytes. (A)
Schematic diagram of the ecdysone inducible system and the pIND-
3XFLAG-Core construct. The recombinant RxR and Ecdysone receptors
are constitutively expressed under RSV and CMV promoters. Upon the
addition of Ponasterone-A, the RxR and Ecdysone receptors bind to the
hybrid ecdysone/glucocorticoid response element and induce the expres-
sion of FLAG-Core protein. (B) Western blot analysis of HCV Core
proteins using anti-Core antibodies (top) and anti-Flag antibodies (bottom)
at 4 and 48 h postinduction with 10 M of Ponasterone A. The bottom
panel is a stripped blot of the top panel and it demonstrates the superior
sensitivity of the anti-FLAG antibodies. NT  nontransfected cells, UI 
uninduced cells.
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(Yamanaka et al., 2002). The different cellular localization
of the two forms of Core protein could have significantly
different effects on cellular processes during early and later
stages of viral infection.
An increase of p21 cdk inhibitor is concurrent with the
appearance of the immature Core protein. We utilized our
inducible Core expression system to determine whether
Core protein expression kinetics affected the cell-cycle reg-
ulators in hepatocytes. Cells were induced with Ponaster-
one-A and harvested 4 and 48 h later. At 4 h postinduction,
both immature and mature forms of Core were present,
while at 48 h postinduction the mature form predominated.
The increased expression of p21 was concurrent with a high
ratio of immature-to-mature form of Core protein (Fig. 3).
Thus, the data suggested a biphasic regulation of p21 ex-
pression, where p21 levels increased early after induction of
unprocessed core protein, but started to decline at later time
points as the mature form accumulated. These results sug-
gest that elevation of p21 seen in core-expressing cells is
associated with the immature form of Core protein. These
results also suggest that the immature form of Core protein
is a more effective regulatory molecule since enhanced
expression of p21 is apparent when very low levels of the
immature form of Core protein are present. Previous studies
reported that the mature form of Core protein repressed p21
expression. In our system, the accumulation of the mature
form of Core was unable to efficiently repress p21 expres-
sion. This may be due to the constant presence of the
immature form. The modulation of p21 levels is dependent
on the ratios of the two Core protein forms that have
counteracting effects.
Elevation of p21 leads to a repression of cdk2 kinase
activity
The p21 protein is the universal cyclin kinase inhibitor
that acts to repress cyclin-dependent kinase activity. There-
fore, we investigated whether the activity of cdk2, the cat-
alytic partner of cyclins A and E, is altered following in-
duction of Core protein expression in HepG2 cells. To
investigate the effects of Core on cdk2 activity, we chose
the 4-h induction time point when the ratio of the immature
form to mature form is greatest, and at the 48-h time point
when most of the Core protein is in the mature form.
Cellular extracts prepared from nontransfected (NT), unin-
duced (UI), and induced cells (IN) were used for Western
blot analysis or cdk2-dependent kinase assays (Fig. 4A).
The levels of p21 were elevated at the 4-h time point and
decreased slightly at the 48 h time point (Fig. 4A). Cdk2
was immunoprecipitated and subjected to a histone kinase
assay. The cdk2-dependent kinase activity at 4 and 48 h
after Core induction was reduced to 55 and 44%, respec-
tively (Fig. 4B). The reduction in cdk2 activity at 48 h time
point reflects the maintenance of p21 up-regulation at 48-h
post-Core induction. Cyclin D/cdk4/6-dependent kinase ac-
tivity was unchanged following the induction of Core pro-
tein (data not shown).
Fig. 4. HCV Core protein enhances p21 expression leading to the repres-
sion of Cdk2 kinase activity. (A) Western blot analysis of p21, Cdk2,
phospho-p53 shows that the increase of p21 expression was not due to
activation of p53 or an increase in expression of Cdk2. (B) Cdk2-dependent
histone kinase assays. The kinase activity of Cdk2 was repressed as the
result of enhanced p21 expression. Histone H1 was used as a substrate.
Cdk2 kinase activities were repressed to the average of 55% at 4 h and 44%
at 8 h post-Core induction, as compared to nontransfected HepG2 cells.
Fig. 3. The p21 expression corresponds to the appearance of the immature
Core protein. Western blot was used to detect expression of Core and p21
proteins. The top panel shows the levels of endogenous p21 expression
corresponding to Core protein expression. The expression of p21 peaked at
4 and 8 h post-Core induction and declined after 8 h post-Core induction.
NT  nontransfected cells, UI  uninduced cells.
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Expression of HCV Core does not alter the expression of
other key cell-cycle regulators
The p21 cdk inhibitor is regulated at transcriptional and
posttranscriptional levels and is a major transcriptional tar-
get of the p53 tumor suppressor (el-Deiry et al., 1993). The
p53 protein is phosphorylated and stabilized following
DNA damage or genotoxic shock (Appella and Anderson,
2001). An increase in p53 expression induces the transcrip-
tion of p21, thus initiating a growth arrest cascade. We
investigated whether the increase in p21 expression follow-
ing Core induction was mediated by p53. Western blot
analysis of cellular extracts from uninduced cells and cells
induced for 4 and 48 h showed that the levels of the
phosphorylated p53 remained unchanged following Core
protein expression (Fig. 4A). Therefore, we conclude that
the increase in p21 levels is mediated by p53 independent
mechanisms. The levels of the cdk2 protein were also un-
changed (Fig. 4A); thus, the decrease of cdk2 kinase activity
is most probably due to the inhibition of the cyclin/cdk2
complex.
The effect of core protein on the expression of regulators
of the cell cycle was examined by the Western blot analysis.
Protein extracts were prepared from hepatocytes induced for
8, 16 and 24 h. The levels of cyclins E, A, and D were
unchanged (Fig. 5). The protein levels of the cdk inhibitors
p27 and p16 were also unchanged. We also determined that
the levels of the RB family of proteins—Rb, p107, and
p130, as well as E2F-1 and E2F-4—were unchanged. These
results suggest that only p21 is subject to regulation by Core
protein in our system.
HCV Core protein reduces the percentage of cells in
S-phase
Previous investigations of Core protein and p21 did not
demonstrate the phenotypic effects resulting from the mod-
ulation of p21 by Core protein. In this study, we sought to
investigate whether the effect of Core protein on p21 ex-
pression and cdk2 activity would result in modification of
hepatocyte proliferation. Using the BrdU incorporation as-
say, we examined the effect of Core protein on the cell-
cycle profile. We demonstrate that Core protein expression
corresponded to a lower percentage of cells in the S-phase
of the cell cycle at 6 h postinduction (Fig. 6). After 24 and
48 h of Core protein expression, the reduction in the pop-
ulation of cells entering S-phase was accompanied by a
reciprocal increase in the number of cells at the G0/G1 phase
of the cell cycle. Statistical analysis indicated that the de-
crease in S-phase cells and an increase in G0/G1 cells were
significant (P  0.05). The retardation of cells in G0/G1
phase of cell cycle is consistent with an increase of p21,
arguing that the elevation of this kinase inhibitor has func-
tional significance.
Fig. 6. Cell-cycle analysis of cells expressing Core protein. Flow cytomet-
ric analysis of nontransfected (NT), uninduced (UI), and induced (IN) Core
protein expressing HepG2 hepatocyte cells shows a decline in the popu-
lation of S-phase cells and an increase in the population of cells in G0/G1.
The decrease in percentage of cells in S phase and an increase in the
percentage of cells in the G0/G1 phase following induction of Core protein
is statistically significant (P  0.05).
Fig. 5. HCV Core protein(s) does not alter the expression of other key
cell-cycle regulators. Western blot analysis shows that the expression of
HCV Core does not affect the expression of key cell-cycle regulators of the
Rb family, cyclins E, A, and D, the Cdk inhibitors p27 and p16, and the
E2F1 and E2F4. Actin serves as a protein loading control.
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Discussion
The goal of this study was to investigate the effect of
HCV core protein on the expression of cell-cycle regulators
in hepatocytes. We successfully constructed an inducible
system to analyze the kinetics of Core protein expression
and processing in hepatocytes. The salient feature of our
system is that Core protein can be detected within 4 h
postinduction, thus providing us with a convenient tool to
study the short-term versus long-term exposure of cells to
Core protein(s). This allowed us to demonstrated a biphasic
effect of Core protein on endogenous p21 expression after
various times of exposure to Core. In previously described
inducible systems, Core protein was not detected early fol-
lowing induction; therefore, the detection of early expres-
sion of the immature form of the Core protein may have
been missed. We have shown that HCV Core protein up-
regulated p21 levels and repressed cdk2-dependent phos-
phorylation. In agreement with previously published results
(Yamanaka et al., 2002), our data suggest that the immature
form of Core up-regulates p21. Importantly, our data also
show that p21 expression was enhanced 4 h post-Core
protein induction, yet the amount of immature form present
in cells at this time was undetectable by commercially
available Core protein antibodies. Therefore, we conclude
that at 4 h postinduction, Core protein was not overex-
pressed and that the expression level may closely resemble
the expression level of Core protein in natural HCV infec-
tions. This analysis provides a plausible explanation for the
widely discrepant results obtained from different studies on
the regulation of p21 by Core protein. Previous studies by
various groups utilized different expression systems that did
not address the unique properties of different Core isoforms
(Ray et al., 1998; Jung et al., 2001; Yoshida et al., 2001; Lu
et al., 1999; Otsuka et al., 2000). Since the immature form
is detected predominantly at very early times after Core
protein expression, many of the studies analyzed the effect
of the mature form of the protein. If the immature form of
Core enhances, while the mature form represses expression
of p21, then the results obtained are dependent on the form
that predominates in the specific experiment. Should the
processing kinetics differ in the individual studies, then the
effect of Core protein on p21 expression would differ as
well.
Since we did not detect an increase of p53 activation by
Core protein, p53 does not appear to be instrumental in p21
induction. Additional Western blot analysis showed that
Core protein had no effect on other key cell-cycle regulators
in our system. In contrast to previously published studies
(Cho et al., 2001a,b), we did not detect a decrease in the
levels of RB or an increase in E2F1 nor an increase of cyclin
E expression. It is noteworthy that in the previously pub-
lished studies, the increase in E2F1 was detected only 72 h
after induction of Core protein. However, these studies
analyzed the effect of Core protein on cyclin E expression in
Rat1 cells; therefore, our studies may not be directly com-
parable (Cho et al., 2001a,b). It is not clear why the imma-
ture form of Core up-regulates p21 leading to the repression
of cdk2 activity. Previous reports indicate that the immature
form of Core localizes to the cytoplasm, while the mature
form localizes to the nucleus. Different subcellular localiza-
tions may determine the protein–protein interactions of
Core protein with the cellular component that results in
modulation of p21 expression.
An increase in the levels of p21 results in retardation of
cell-cycle progression, which is contradictory to the pro-
posed role of Core protein in cellular transformation.
Changes in p21 stoichiometry, relative to the other compo-
nents of these complexes, result in suppression of cdk ac-
tivity, allowing the accumulation of hypophosphorylated
Rb, inhibition of E2F-dependent transcriptional processes,
and cell-cycle arrest in G1 (Harper et al., 1995). As pre-
dicted, we observed a decrease of cdk2 activity and an
accumulation of cells in the G0/G1 phase of cell cycle that
was coincident with elevated expression of p21. It is pos-
sible that the biphasic effect on important growth control
proteins is a component of the viral life cycle. Biphasic
effects on key cell-cycle regulators have been demonstrated
for human cytomegalovirus (HCMV). Early after HCMV
infection, cyclin A expression is repressed, while at later
times in the viral infection, cyclin A expression is induced
(Salvant et al., 1998). Early in the HCV life cycle, it may be
advantageous for the virus to arrest or slow cell prolifera-
tion. The cell-cycle arrest may serve to protect cells from
apoptosis during the initial stage of infection. An alternative
explanation is that during the early stage of infection, the
immature Core modulates the expression of proteins that are
required for repression of the immune response and facili-
tates the escape from immunosurveillance. The up-regula-
tion of p21 could also be a result of an increase in TGF-1,
a protein that has been shown to activate expression of p21
in a p53-independent manner (Datto et al., 1995). Studies
have shown that Core protein modulates p21 expression
through the TGF- pathway (Lee et al., 2002). TGF-1 has
been shown to have a repressive effect on T cells (Cook et
al., 1999). By suppressing the immune system during the
early stages of infection, HCV can enhance its ability to
establish chronic infection. The evidence of increased
TGF- expression in liver samples of HCV-infected pa-
tients has been well documented (Nelson et al., 1997). p21
can also stimulate NF-B-dependent gene expression
through an interaction with cyclin-dependent kinases, NF-
B, and the coactivators p300 and CAAT-binding protein
(Perkins et al., 1997). The multiple activities of p21 provide
a mechanism for the coordination of transcriptional activa-
tion with cell-cycle progression.
In summary, our results demonstrate that early after
induction of Core protein expression, two distinct isoforms
corresponding to an immature and mature form of Core
protein are detected. During the initial 8 h of induction, the
ratios of the immature-to-mature form are higher than at
later times, where the mature form accumulates. Core pro-
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tein modulates the expression of p21 in a biphasic manner
and the immature form of the protein is associated with
increased expression of this cdk inhibitor. The elevation of
p21 coincides with a decrease in cdk2-dependent kinase
activity. These changes in p21 and cdk2 activity lead to a
decrease in cellular proliferation. Since there was no in-
crease in the level of activated p53, the increase of p21
occurs in a p53-independent manner. We did not detect
changes in the levels of 11 other cell-cycle regulatory pro-
teins, suggesting the HCV Core protein primarily targets the
p21 to modify cell-cycle controls. These studies provide
better insights into the effect of HCV core protein on the
cell-cycle regulation of hepatocytes.
Materials and methods
Cell culture
HepG2 cells were obtained from ATCC (Manassas, VA).
Cells were maintained in DMEM supplemented with 10%
fetal bovine serum, 2 mM L-glutamine, and 100 U of pen-
icillin-streptomycin/ml (GIBCO-BRL, Rockville, MD).
Plasmids
The inducible plasmid pIND-3XFLAG-Core was gener-
ated by cloning the N-terminus FLAG-tagged Core coding
sequence into the inducible expression vector pIND with a
neomycin selection marker (Invitrogen). The generation of
the 3XFLAG-Core coding sequence involved multiple sub-
cloning steps. Briefly, the HCV-1b coding sequence from
plasmid pBR394J1 was obtained from Dr. Miyamura
(Aizaki et al., 1998). The Core-E1-E2 coding sequence was
excised from the pBR394J1 plasmid with XbaI and NheI
restriction enzymes and subcloned into the XbaI site of
pUC-18 plasmid to make pUC-18-Core-Env plasmid. The
HindIII/EcoRI fragment from pUC-18-Core-Env was fur-
ther subcloned into the HindIII/EcoRI restriction sites of the
p3XFLAG-CMV-10 plasmid (Sigma, St. Louis, MO) to
generate p3X-Core-Env plasmid that contains the FLAG tag
coding sequence upstream and in-frame of the Core coding
sequence. Using 3XFLAG forward primer (ATAAC-
CCCGCCCCGTTGA) and Core-stop reverse primer (AG-
GAATTCCACTTCCCTAAGCGGA), we amplified the se-
quence containing the FLAG-Core sequence with a stop
codon after Core’s 191st codon (bold) by the polymerase
chain reaction (PCR). The FLAG-Core PCR product was
digested with SacI and EcoRI restriction enzymes and in-
serted into the SacI and EcoRI sites of the pIND plasmid to
generate the pIND-3XFLAG-Core plasmid. The plasmid
pVgRxR (Invitrogen) encodes the RxR and VgEcR ecdy-
sone receptor subunits and contains a Zeocin selection
marker.
Transfection and establishment of a Core-inducible stable
cell line
HepG2 cells were cotransfected with linearized pIND-
3XFLAG-Core and pVgRxR plasmids by electroporation of
5  106 cells in 0.5 ml of growth media without serum at
250 V and 950 F using a Gene Pulser (Bio-Rad, Hercules,
CA) and grown on a 60-mm dish overnight. The transfected
cells were grown in selection media containing 1000 g/ml
of G418 and 200 g/ml of Zeocin for 2 weeks. The surviv-
ing cell colonies were isolated and transferred into 24-well
plates and maintained in selection media for two to three
more weeks. Cell clones that survived the second round of
selection were plated in 25-mm flasks and expanded for
further evaluation.
Immunoblot analysis
Cells were lysed in RIPA buffer and 30 g of total
protein was separated on SDS–PAGE gels. Each gel was
transferred to BA-85 membrane (Schleicher and Schuell,
Keene, NH). The membrane was stained with Ponceau S to
ensure equal loading of protein and blocked with 5% nonfat
dry milk in phosphate-buffered saline (PBS) and 0.1%
Tween for 1 h before the addition of specific antibodies. The
following antibodies were used: cyclin E antibody (gener-
ous gift from Dr. G. Lozano), p21, cdk2, p27, p16, cyclin A,
cyclin D, p130, p107, pRB, E2F1, E2F4, and Actin (Santa
Cruz Biotechnologies, Santa Cruz, CA), Flag antibodies
(Stratagene, La Jolla, CA), and the Core antibody (Maine
Biotechnology Services, Inc., Portland, ME). After washing
and incubation with secondary mouse monoclonal or rabbit
polyclonal horseradish peroxidase linked antibodies (Am-
ersham Pharmacia, Piscataway, NJ), proteins were detected
using ECL (Amersham Pharmacia) following manufac-
turer’s recommendations.
In vitro kinase assays
In vitro kinase assays were performed as previously
described (Chuang et al., 1997). Briefly, cells were lysed in
NP-40 lysis buffer, the extracts were precleared and incu-
bated with cdk2 antibodies (Santa Cruz). The antibody/
protein complexes were isolated on Protein A/Protein G
agarose beads (Oncogene Science, Cambridge, MA),
washed, and resuspended in kinase buffer (1 mg/ml Histone
H1, 1 mM ATP, 1 Ci/l [32P] ATP, 20 mM HEPES pH
7.0, 80 mM -glycerolphosphate, 20 mM EGTA, 50 mM
MgCl2, 5 mM MnCl2, 1 mM DTT, 2.5 mM PMSF, 10 M
camp protein kinase inhibitor). The kinase reaction was
terminated by addition of gel loading buffer and the protein
was separated on 12% SDS–PAGE. The gel was fixed,
dried, and autoradiographed. The radioactive bands were
excised from the gel and the radioactivity was quantitated
using a scintillation counter.
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Measurement of BrdU incorporation and DNA content
Cells were seeded at 3 105 cells/well in six-well plates
and cultured overnight to allow attachment and growth.
Cells were induced for 6, 24, and 48 h with 10 M of
Ponasterone A. Cells were labeled with bromodeoxyuridine
(BrdU) and 7-aminoactinomycin-D (7-AAD) according to
the manufacturer’s recommendations (BD PharMingen,
CA). Briefly, cells were incubated with 10 M of BrdU for
45 min and then trypsinized to make single cell suspension.
Cells were washed, fixed, and permeabilized with appropri-
ate solutions. Cells were treated with DNAse I for 1 h at
37°C to expose incorporated BrdU. Anti-BrdU antibody and
7-AAD stain were added to cells and cell samples were
analyzed by flow cytometry.
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